Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 10, 2015

View Archived Issues

Preclinical and phase I efficacy of a first-in-class ADC against tumor-initiating cells

RedHill Biopharma reports additional data from phase III RHB-105 study

Domain Therapeutics identifies mGlu2/3 receptor modulators for PD non-motor symptoms

GeoVax's Ebola vaccine shows efficacy in rodent models

Pierre Fabre and Addex Therapeutics form CNS program agreement

Recent agreements to develop cancer drugs and diagnostics

Faron Pharmaceuticals announces share offer to fund phase III trial of Traumakine

Purdue Pharma acquires rights to TrkA program from VM Pharma

Canadian funding for VBI Vaccines' development of RSV vaccine

New antimalarial classes discovered at the Walter Reed Army Institute

FDA grants priority review to ixazomib for relapsed/refractory multiple myeloma

Santhera receives European approval for Raxone in Leber's hereditary optic neuropathy

University of New Mexico and HHS discover new PCSK9 vaccine

Team in France introduces AAC-11-LZ-derived polypeptides

Achillion presents complement factor D inhibitors

Shanghai Haiyan Pharmaceutical Technology introduces selective inhibitors of mutant EFGR

EPIRUS patents Nav1.7 channel blockers

Responses seen with TargomiRs in mir-16-deficient mesothelioma

Bioequivalence shown for potential biosimilar PF-06439535 and bevacizumab in healthy volunteers

Novo Nordisk and MIT to explore next generation of drug delivery devices

Rockwell Medical launches Triferic for iron deficiency in the U.S.

Recent acquisition news

Progression-free survival improved with anlotinib in refractory NSCLC

Grant supports Treeway's investigation into ALS diagnostic tool

Janssen-Cilag seeks European approval for daratumumab in multiple myeloma

Cara Therapeutics starts pivotal phase II/III trial for CR-845 in acute postoperative pain

GenSpera reports interim results from phase II trial of mipsagargin in glioblastoma

Trimel Pharmaceuticals changes name to Acerus Pharmaceuticals

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...